Pharming provides update on outstanding shares
(Thomson Reuters ONE) - Leiden, The Netherlands, September 30, 2009. Biotech companyPharming Group NV ("Pharming" or "the Company") (NYSE Euronext:PHARM) today provided an update on its outstanding number of shares.Pharming issued 2,927,230 ordinary shares under the Standby EquityDistribution Agreement with YA Global Master SPV LTD ("YA Global")for a cash consideration of ? 1.5 million. In addition, the Companyissued shares in private placements with existing shareholders inorder to support the bond conversion transaction as announcedSeptember 21, 2009. As a result, Pharming's total number ofoutstanding ordinary shares is currently 120,850,520.About Pharming Group NVPharming Group NV is developing innovative products for the treatmentof genetic disorders, ageing diseases, specialty products forsurgical indications, intermediates for various applications andnutritional products. Pharming has two products in late stagedevelopment - Rhucin® for Hereditary Angioedema and human Lactoferrinfor use in food products and one product in early stage clinicaldevelopment - Prodarsan® for Cockayne Syndrome. The advancedtechnologies of the Company include innovative platforms for theproduction of protein therapeutics, technology and processes for thepurification and formulation of these products, as well as technologyin the field of DNA repair (via DNage). Additional information isavailable on the Pharming website, http://www.pharming.com.This press release contains forward looking statements that involveknown and unknown risks, uncertainties and other factors, which maycause the actual results, performance or achievements of the Companyto be materially different from the results, performance orachievements expressed or implied by these forward lookingstatements.Contact:Ms. Marjolein van Helmond, Pharming Group NV, T: +31 (0)71 52 47 431or +31 (0)6 109 299 54http://hugin.info/132866/R/1345076/322709.pdfThis announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.
Datum: 30.09.2009 - 18:30 Uhr
Sprache: Deutsch
News-ID 6447
Anzahl Zeichen: 0
contact information:
Town:
London
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 243 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Pharming provides update on outstanding shares"
steht unter der journalistisch-redaktionellen Verantwortung von
Pharming Group N.V. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
